COVID-19 Molecular Diagnostics Fueling Growth of Global Infectious Disease In-Vitro Diagnostics Market

The global infectious disease in-vitro diagnostics market is projected to record promising growth over the 2020-2030 period on back of the rising prevalence of infectious diseases around the world, particularly COVID-19.

These are the latest findings of TMR Research (San Francisco, CA, USA), a provider of customized market research and consulting services.

Infectious disease in-vitro diagnostic tests perform the function of detecting and identifying the specific infectious agent to establish its origin and enable healthcare professionals to provide the ideal treatment to a patient. These tests can also help in overcoming potential epidemics. This is acting as a vital growth generator for the infectious disease in-vitro diagnostics market. The increasing incidences of infectious diseases and the growing need to tackle them at an early stage have led to tremendous advancements in terms of diagnostics. Infectious disease in-vitro diagnostics is one of them. Thus, this will bring good growth opportunities for the infectious disease in-vitro diagnostics market.

The overwhelming use of infectious disease in-vitro diagnostics in point-of-care testing, central laboratories and others will create immense growth prospects for the market. The growing influence of infectious disease in-vitro diagnostics in detecting a variety of infections such as respiratory viruses, Chlamydia, HPV, Gonorrhea, Clostridium Difficile, MRSA, Streptococcus, Hepatitis B, HIV, Hepatitis C, COVID-19, and others will serve as a vital growth-generator.

The COVID-19 pandemic has wreaked havoc across the globe due to the rising transmission rates and fatality rates. The most efficient way to decrease the mortality rate and prevent infecting others is an intense focus on testing. For COVID-19 testing, RT-PCR (real-time reverse transcription-polymerase chain reaction) is regarded as a gold standard. This testing method is the clinical gold standard for the etiological diagnosis of COVID-19 in which viral DNA is directly detected. RT-PCR tests are being considered as the best option for COVID-19 testing around the world. The growing popularity of these testing methods will create huge growth prospects for the infectious disease in-vitro diagnostics market.

Manufacturers in the infectious disease in-vitro diagnostics market are developing kits that are easier for home use. These kits are designed for home-testing and treatments. Self-testing kits are useful for early diagnosis and consistent patient monitoring. They are also important for curbing costs. Hence, the rising demand for self-testing kits is directly proportional to the growth of the infectious disease in-vitro diagnostics market.

Geographically, North America will continue to dominate the global infectious disease in-vitro diagnostics market with the largest share between 2020 and 2030 on the back of the rising COVID-19 infections across the region. However, the Asia Pacific infectious disease in-vitro diagnostics market is expected to record the fastest growth during this period.

Related Links:
TMR Research